More about

Pancreatic Cancer

News
January 21, 2022
2 min read
Save

Adagrasib active, safe among patients with KRAS G12C-mutated pancreatic, GI tumors

Adagrasib active, safe among patients with <i>KRAS</i> G12C-mutated pancreatic, GI tumors

Adagrasib induced promising clinical activity as monotherapy among pretreated patients with unresectable or metastatic pancreatic cancer and other gastrointestinal tumors that harbor a KRAS G12C mutation, according to study results.

News
January 21, 2022
2 min read
Save

Adagrasib active, safe among patients with KRAS G12C-mutated pancreatic, GI tumors

Adagrasib active, safe among patients with <i>KRAS</i> G12C-mutated pancreatic, GI tumors

Adagrasib induced promising clinical activity as monotherapy among pretreated patients with unresectable or metastatic pancreatic cancer and other gastrointestinal tumors that harbor a KRAS G12C mutation, according to study results.

News
January 20, 2022
2 min read
Save

IgG4-related disease linked to increased risk for lymphoma, pancreatic cancer

IgG4-related disease linked to increased risk for lymphoma, pancreatic cancer

Patients with IgG4-related disease are at a higher risk for cancer — particularly pancreatic and lymphoma — compared with the general population, according to a meta-analysis published in Arthritis Research & Therapy.

News
January 16, 2022
1 min read
Save

Gastrointestinal cancer specialist joins Henry Ford Cancer Institute

Gastrointestinal cancer specialist joins Henry Ford Cancer Institute

Philip A. Philip, MD, PhD, has been appointed director of gastrointestinal oncology and neuroendocrine oncology at Henry Ford Cancer Institute.

News
December 29, 2021
1 min read
Save

Top in hem/onc: Dietary supplements in adults with cancer, ASCO names 2023-2024 president

Top in hem/onc: Dietary supplements in adults with cancer, ASCO names 2023-2024 president

Many adults who were diagnosed with cancer said they use dietary supplements because they believe the supplements will help lower their risk for disease recurrence, according to a recent study.

News
November 11, 2021
4 min read
Save

More research needed on pancreatic cancer treatment strategies, expert says

More research needed on pancreatic cancer treatment strategies, expert says

Despite a significant amount of data in the adjuvant setting for pancreatic cancer, more research is needed to better define perioperative and neoadjuvant treatment strategies, according to a speaker at Chemotherapy Foundation Symposium.

News
November 10, 2021
13 min read
Save

New-onset diabetes provides ‘window of opportunity’ for early pancreatic cancer detection

Pancreatic cancer often is called the silent killer.

News
October 28, 2021
2 min read
Save

Devimistat regimen fails to extend OS in metastatic pancreatic cancer

Devimistat regimen fails to extend OS in metastatic pancreatic cancer

Devimistat plus a modified standard-of-care chemotherapy regimen failed to extend OS among patients with metastatic pancreatic cancer, according to results of the randomized phase 3 AVENGER 500 trial released by the agent’s manufacturer.

News
October 15, 2021
3 min read
Save

Ablative MRI-guided radiation therapy extends survival in inoperable pancreatic cancer

Ablative MRI-guided radiation therapy extends survival in inoperable pancreatic cancer

Ablative MRI-guided radiation therapy prolonged survival compared with standard therapy among patients with inoperable pancreatic cancer, according to results presented during the European Society for Radiotherapy and Oncology Congress.

News
October 15, 2021
1 min read
Save

CDKN2A mutation surveillance leads to earlier pancreatic cancer detection

CDKN2A mutation surveillance leads to earlier pancreatic cancer detection

Surveillance of patients carrying the CDKN2A gene mutation led to earlier detection of pancreatic ductal adenocarcinoma which improved disease prognosis, according to a presenter at UEG Week.

View more